Skip to main content
. 2016 Mar 29;20(7):1392–1407. doi: 10.1111/jcmm.12817

Table 3.

Immunotherapy‐based agents

Agents Details Agents under investigation Status Ref.
Active immunotherapy agents (Vaccine) DNA vaccine pCMVE/MDC‐3Aβ11 PADRE‐C3d 103
Epitope‐/protein‐/VLP‐based vaccine Adeno‐10× Aβ3 – 10+ CpG
Prime‐boost approach Aβ1‐42 peptide prime/Aβ1‐42 DNA + QuilA
Passive immunotherapy agents Monoclonal antibody Bapineuzumab
Solanezumab
(III) 64